Status:
COMPLETED
Magnesium Chloride Versus Placebo in Patients Who Have Had a Stroke
Lead Sponsor:
Relox Medical, LLC
Conditions:
Stroke
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to evaluate the effect of six intravenous (IV) infusions of magnesium chloride versus placebo in patients who have residual muscle weakness from a stroke that occurred thr...
Detailed Description
The hypothesis being tested is that these six treatments will improve muscle weakness and lead to an improvement in functioning/activities of daily living as measured by the 100-point Barthel index, t...
Eligibility Criteria
Inclusion
- Subjects of either sex above 18 years of age
- Documented history of stroke 3 months to four years ago
- Subjects may have had two or more strokes
- Must have residual muscle weakness with a 25% or greater difference in strength between the right and left sides of the body
- Must be assessed as a 2 or 3 on the Modified Rankin Scale
- Must have a Barthel score at or below 85
Exclusion
- Any traumatic brain injury or other brain injury apart from stroke
- Renal insufficiency or renal failure
- Any medical or physical condition that would interfere with the measurements to be conducted
- Any physical therapy in a facility outside their home within three days of screening
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT00933868
Start Date
April 1 2009
End Date
July 1 2010
Last Update
May 25 2012
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Born Preventive Healthcare Clinic, PC
Grand Rapids, Michigan, United States, 49512
2
Schachter Center for Complementary Medicine
Suffern, New York, United States, 10901
3
Comprehensive Heart Care Inc.
Toledo, Ohio, United States, 43606